These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21291331)

  • 21. Analysis of the NovoPen® Echo for the delivery of insulin: a comparison of usability, functionality, and preference among pediatric subjects, their parents, and health care professionals.
    Reynholds C; Antal Z
    J Diabetes Sci Technol; 2010 Nov; 4(6):1476-8. PubMed ID: 21129344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Injection force of SoloSTAR® compared with other disposable insulin pen devices at constant volume flow rates.
    van der Burg T
    J Diabetes Sci Technol; 2011 Jan; 5(1):150-5. PubMed ID: 21303637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative device assessments: Humalog KwikPen compared with vial and syringe and FlexPen.
    Ignaut DA; Schwartz SL; Sarwat S; Murphy HL
    Diabetes Educ; 2009; 35(5):789-98. PubMed ID: 19783767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, open-label, comparative crossover handling trial between two durable pens in patients with type 1 or 2 diabetes mellitus.
    Sommavilla B; Pietranera G
    J Diabetes Sci Technol; 2011 Sep; 5(5):1212-21. PubMed ID: 22027321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of dose selection attributes with audible notification in insulin pen devices.
    Asakura T; Seino H
    Diabetes Technol Ther; 2005 Aug; 7(4):620-6. PubMed ID: 16120036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose accuracy of SoloSTAR and FlexPen as assessed in a clinical setting.
    Friedrichs A
    Diabetes Technol Ther; 2009 Sep; 11(9):609-13. PubMed ID: 19764841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trigger matters: an ergonomy analysis of insulin pens.
    Fendler W; Roman-Liu D; Tokarski T; Romanczuk R; Mlynarski W
    Diabetes Technol Ther; 2015 Mar; 17(3):171-6. PubMed ID: 25607378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correct use of a new reusable insulin injection pen by patients with diabetes: a design validation study.
    Schwartz S
    J Diabetes Sci Technol; 2010 Sep; 4(5):1229-35. PubMed ID: 20920444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humalog(®) KwikPen™: an insulin-injecting pen designed for ease of use.
    Schwartz SL; Ignaut DA; Bodie JN
    Expert Rev Med Devices; 2010 Nov; 7(6):735-43. PubMed ID: 21050084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do different body colors and labels of insulin pens enhance a patient's ability to correctly identify pens for injecting long-acting versus short-acting insulins?
    Lefkowitz M
    J Diabetes Sci Technol; 2011 Jan; 5(1):136-49. PubMed ID: 21303636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in the dose accuracy of insulin pens.
    Hänel H; Weise A; Sun W; Pfützner JW; Thomé N; Pfützner A
    J Diabetes Sci Technol; 2008 May; 2(3):478-81. PubMed ID: 19885213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose accuracy and injection force dynamics of a novel disposable insulin pen.
    Clarke A; Spollett G
    Expert Opin Drug Deliv; 2007 Mar; 4(2):165-74. PubMed ID: 17335413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attributes Influencing Insulin Pen Preference Among Caregivers and Patients With Diabetes Who Require Greater Than 20 Units of Mealtime Insulin.
    Wang T; Conrad KA; van Brunt K; Rees TM
    J Diabetes Sci Technol; 2016 Jul; 10(4):923-31. PubMed ID: 26920640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineering study comparing injection force and dose accuracy between two prefilled insulin injection pens.
    Ignaut DA; Opincar MR; Clark PE; Palaisa MK; Lenox SM
    Curr Med Res Opin; 2009 Dec; 25(12):2829-33. PubMed ID: 19916727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dosing accuracy with a novel pen device (SoloSTAR) as performed by patients with diabetes in a clinical setting.
    Hermanns N; Kulzer B; Haak T
    Diabetes Technol Ther; 2008 Aug; 10(4):322-7. PubMed ID: 18715206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosing accuracy of two insulin pre-filled pens.
    Asakura T; Seino H; Kageyama M; Yohkoh N
    Curr Med Res Opin; 2008 May; 24(5):1429-34. PubMed ID: 18400146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ease of use and preference of a new versus widely available prefilled insulin pen assessed by people with diabetes, physicians and nurses.
    Oyer D; Narendran P; Qvist M; Niemeyer M; Nadeau DA
    Expert Opin Drug Deliv; 2011 Oct; 8(10):1259-69. PubMed ID: 21905942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usability, participant acceptance, and safety of a prefilled insulin injection device in a 3-month observational survey in everyday clinical practice in Australia.
    Carter J; Beilin J; Morton A; De Luise M
    J Diabetes Sci Technol; 2009 Nov; 3(6):1425-38. PubMed ID: 20144398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Force requirements and insulin delivery profiles of four injection devices.
    Toraishi K; Yuizono Y; Nakamura N; Kato S; Aoki T; Ashida K; Sako Y
    Diabetes Technol Ther; 2005 Aug; 7(4):629-35. PubMed ID: 16120038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin delivery with FlexPen: dose accuracy, patient preference and adherence.
    Pfützner A; Asakura T; Sommavilla B; Lee W
    Expert Opin Drug Deliv; 2008 Aug; 5(8):915-25. PubMed ID: 18713000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.